Latest News about BLUE
Recent news which mentions BLUE
Bluebird Bio Posts Updated Data From Sickle Cell Gene Therapy Program
December 13, 2021
Tickers
BLUE
From Benzinga
22 Stocks Moving in Monday's Pre-Market Session
December 13, 2021
From Benzinga
The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More
December 12, 2021
From Benzinga
2 Popular Healthcare Stocks I'd Avoid at All Costs
December 03, 2021
From Motley Fool
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 22, 2021
From Benzinga
From InvestorPlace
Bluebird Bio's Thalassemia Gene Therapy Under Priority Review With FDA
November 22, 2021
Tickers
BLUE
From Benzinga
Better Buy: Vertex Pharmaceuticals vs. CRISPR
November 20, 2021
From Motley Fool
64 Biggest Movers From Yesterday
November 09, 2021
From Benzinga
Why Bluebird Bio Stock Plunged Today
November 08, 2021
From Motley Fool
38 Stocks Moving In Monday's Mid-Day Session
November 08, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 08, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2021
November 08, 2021
From Benzinga
92 Biggest Movers From Friday
November 08, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
November 05, 2021
From Benzinga
64 Stocks Moving In Friday's Mid-Day Session
November 05, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 05, 2021
From Benzinga
28 Stocks Moving in Friday's Pre-Market Session
November 05, 2021
From Benzinga
28 Stocks Moving in Friday's Pre-Market Session
November 05, 2021
From Benzinga
2 Upcoming FDA Approval Decisions That Investors Should Really Watch
October 23, 2021
From Motley Fool
Bluebird Bio To Withdraw Marketing Of Skysona Gene Therapy In Europe
October 21, 2021
Tickers
BLUE
From Benzinga
3 Under-the-Radar COVID Stocks
October 20, 2021
From Motley Fool
Could This Beaten-Down Biotech Stock Be the Next Buyout Target?
October 20, 2021
From Motley Fool
From InvestorPlace
2 Tricks and a Treat for Gene Therapy Investors
October 18, 2021
From Motley Fool
2 Top Healthcare Stocks That Could Be Bought Out in 2022
October 16, 2021
From Motley Fool
From Motley Fool
The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
September 22, 2021
From Benzinga
Bluebird Bio Files US Application For β-thalassemia Gene Therapy
September 22, 2021
Tickers
BLUE
From Benzinga
7 Gene Editing Stocks Promising to Change our DNA
September 15, 2021
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.